KIDS

OrthoPediatrics Corp.

$32.58

-3.24%
SectorHealthcareIndustryMedical DevicesCountryUnited States

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity in children; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIRO Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, Mitchell Ponseti, VerteGlideTM, and Boston Brace 3D.

Source: Yahoo Finance
AI summary

Price & performance

1M+38.5%
3M+57.7%
YTD+79.5%
1Y+91.5%
52-week range—
Beta1.14
Full chart and returns against a benchmark

Q-Score

62/ 100

Quality against peers; 50 is the peer median.

Growth68
Risk63
Performance53
Valuation59
Profitability59
Leverage49
Sentiment25
Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue$236.3M+15.4%
Net income-$39.6M
Net margin-16.8%+1.7 pts
Historical fundamentals

Revenue exposure

21%of revenue from outside the US
United States79%
Non-US21%
Regions, segments, customers and suppliers

Valuation

KIDSIndustryP/E—29.61P/S3.223.49EV/EBITDA—18.38P/B2.513.39PEG——
Dividend yield0.00%
Every valuation metric

Earnings

Oct 27next report, after the close
EPS estimate$-0.21
Beats (last 4 quarters)—
Average surprise—
EPS revisions (30d)—
Every quarter against its estimate